| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH |
From RAND, Santa Monica, California; the Veterans Affairs Medical Center, Los Angeles, California; the Departments of Medicine and Health, Management, and Policy, University of Michigan, Ann Arbor, Michigan; and the Veterans Affairs Medical Center, Ann Arbor, Michigan.
Address reprint requests to: Melissa K. Rowe, PhD RAND PO Box 2138 1700 Main Street Santa Monica, CA 90497–2138 E-mail: melissa-rowe{at}rand.org
Objective: To measure the association between gynecologic conditions and quality of life in women before hysterectomy.
Methods: We retrospectively identified 482 women who had hysterectomies for nononcologic and nonemergency indications in one of nine capitated medical groups in Southern California between 1993 and 1995. Their symptoms and quality of life before hysterectomy were assessed by medical record review and telephone interview. Women were placed into four symptom-based groups (pain, bleeding, pelvic discomfort, and asymptomatic groups) and compared across six quality-of-life scales.
Results: Women with primary pain conditions reported the highest average role impairment compared with women with primary bleeding, pelvic discomfort, or asymptomatic conditions (8.6 days/month versus 5.0, 2.5, and 1.9 days/month, respectively; P < .05). On the five 0 to 100–point quality-of-life scales, women with primary pain conditions, compared with women with bleeding, pelvic discomfort, or asymptomatic conditions, had the highest mean levels of sexual impairment (71.5 versus 54.1, 29.6, and 17.9, respectively; P < .05) and mood impairment (55.2 versus 45.2, 34.6, and 38.1, respectively; P < .05), the poorest perception of general health (74.4 versus 60.7, 44.1, and 49.4, respectively; P < .05), and the greatest increase in severity of symptoms before hysterectomy (77.2 versus 68.7, 61.5, and 57.1, respectively; P < .05).
Conclusion: Women’s primary symptoms before hysterectomy are associated differentially with varying levels of impairment. Standardized measurement of quality of life among women with gynecologic complaints that lead to hysterectomy might help in the development of treatment guidelines and in the assessment of appropriateness and outcomes of care for those women.
This article has been cited by other articles:
|
|
 |
|
  R. A. Bucek, S. Puchner, and J. Lammer Mid- and Long-Term Quality-of-Life Assessment in Patients Undergoing Uterine Fibroid Embolization. Am. J. Roentgenol., March 1, 2006; 186(3): 877 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Hartmann, C. Ma, G. M. Lamvu, P. W. Langenberg, J. F. Steege, and K. H. Kjerulff Quality of Life and Sexual Function After Hysterectomy in Women With Preoperative Pain and Depression Obstet. Gynecol., October 1, 2004; 104(4): 701 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Wallach and N. F. Vlahos Uterine Myomas: An Overview of Development, Clinical Features, and Management Obstet. Gynecol., August 1, 2004; 104(2): 393 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Bree and R. C. Carlos US for Postmenopausal Bleeding: Consensus Development and Patient-centered Outcomes Radiology, March 1, 2002; 222(3): 595 - 598. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
